Moore, Joanna K.

Safety profile of autologous macrophage therapy for liver cirrhosis

Moroni, F., Dwyer, B. J., Graham, C., Pass, C., Bailey, L., Ritchie, L., Mitchell, D., Glover, A., Laurie, A., Doig, S., et al. (2019) · Nature Medicine

Liver physiology and pathologyLiver Disease and Transplantation

Cited by 202

Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial

Newsome, P. N., Fox, R., King, A. L., Barton, D., Than, N.-N., Moore, J., Corbett, C., Townsend, S., Thomas, J., Guo, K., et al. (2018) · The Lancet Gastroenterology & Hepatology

Liver Disease and TransplantationMesenchymal stem cell research

Cited by 162

Patients with the worst outcomes after paracetamol (acetaminophen)‐induced liver failure have an early monocytopenia

Moore, J. K., MacKinnon, A. C., Man, T. Y., Manning, J. R., Forbes, S. J., & Simpson, K. J. (2017) · Alimentary Pharmacology & Therapeutics

Drug-Induced Hepatotoxicity and ProtectionLiver Disease and Transplantation

Cited by 28